Wednesday, 13 May 2026
HPS Diagnosis and Treatment: What Happens in the Hospital When Hantavirus Gets Serious
 |
Doctor explaining Hantavirus Pulmonary Syndrome diagnosis and hospital treatment to patient |
The Hospital Conversation Nobody Wants to Have: But You Need to Know
I've had this conversation dozens of times in my career, and it's never easy.
A patient comes to the emergency room—sometimes gasping for breath, sometimes just feeling terrible with a fever that won't quit. Their family is terrified. And I have to tell them: "We think you have hantavirus. We're running tests. You're going to need to stay in the hospital. We need to monitor your oxygen levels very closely."
The next question is always the same: "What happens now? What's the treatment? Am I going to be okay?"
That's what this article is about. I want you to understand what actually happens when someone develops Hantavirus Pulmonary Syndrome severe enough to require hospitalization. Because knowledge—understanding the diagnosis process, the treatment options, what to expect—that helps patients and families feel less helpless when they're in crisis.
Let me walk you through it the way I explain it to my patients: honestly, clearly, and with compassion.
Part 1: How Doctors Diagnose HPS (The Testing Process)
Here's the first challenge with HPS diagnosis: Early symptoms look exactly like flu.
A patient comes in with fever, muscle aches, and fatigue. Without knowing about rodent exposure, a doctor might think, "Probably COVID or seasonal flu. Let's check." And those tests come back negative. Then what?
That's why the history is crucial: "Have you been around mice or mouse droppings in the past 8 weeks?"
If the answer is yes, and the patient is progressing to respiratory symptoms, hantavirus testing becomes urgent (CDC Diagnostic Guidelines, 2024).
Step 1: Clinical Assessment & History
Doctors look for these clues:
- 📋 Rodent exposure in the past 1-8 weeks (cleaning droppings, living in affected area, working in contaminated space)
- 📋 Fever + severe muscle pain (the combination is suspicious for HPS)
- 📋 Rapid progression to respiratory symptoms within 3-7 days
- 📋 Young to middle-aged patient (HPS doesn't care about age, but can be more severe in elderly or immunocompromised)
- 📋 Declining oxygen levels on pulse oximeter (normal is 95-100%; HPS patients drop to 80-90%)
- 📋 Bilateral infiltrates on chest X-ray (fluid in both lungs, not just one—this is classic for HPS)
If a doctor sees this pattern—especially with rodent exposure history—they'll think HPS and order specific tests (NIH Clinical Recognition Guide, 2024).
 |
HPS diagnosis process including chest X-ray, blood tests and medical imaging |
Step 2: Blood Tests (Serological & Molecular)
This is how doctors actually confirm HPS.
| Test Type | What It Detects | Timing | Accuracy |
|---|---|---|---|
| Serology (IgM Antibody) Tests for hantavirus-specific IgM antibodies in blood |
Early immune response to virus; indicates acute infection | Positive by Day 1-5 of symptom onset; peaks Day 7-10 | ⭐⭐⭐⭐ Highly specific; usually positive by the time patient reaches hospital |
| Serology (IgG Antibody) Tests for hantavirus-specific IgG antibodies |
Later immune response; indicates past or recent infection | Appears after Day 5; remains for months/years | ⭐⭐⭐⭐ Diagnostic; confirms infection but develops more slowly |
| RT-PCR (Molecular Test) Detects viral RNA in blood |
Direct detection of virus genetic material | Positive early in infection; may become negative as antibodies develop | ⭐⭐⭐⭐⭐ MOST SENSITIVE early on; can catch infection before antibodies develop |
| Culture (Viral Culture) Attempts to grow virus in laboratory |
Presence of live infectious virus | Takes 3-7 days for results | ⭐⭐ Rarely done clinically; mainly for research |
In practice, here's what happens: A patient presents with respiratory symptoms and rodent exposure history. The doctor orders IgM serology + RT-PCR. Results usually come back within 24 hours. If IgM or RT-PCR is positive, diagnosis is confirmed as HPS. The patient is typically already hospitalized and treatment has already begun (CDC Laboratory Testing, 2024).
Step 3: Chest Imaging (X-ray or CT Scan)
This is often the most telling test.
When a doctor orders a chest X-ray on an HPS patient, they see something very specific: bilateral pulmonary edema—fluid in both lungs, spreading from the center outward (American Journal of Roentgenology, 2023).
What it looks like: The lungs appear white/gray instead of black. It looks like fluid is filling the lungs, because that's exactly what's happening. The virus damaged the capillaries, and fluid leaked out into the air spaces.
This finding is classic for HPS and helps differentiate it from pneumonia (which usually affects one area) or other respiratory diseases (Radiology Today, 2024).
Step 4: Complete Blood Count (CBC) & Chemistry Panel
Doctors also check:
- 💉 Platelets: HPS often causes thrombocytopenia (low platelet count), sometimes critically low
- 💉 Hematocrit: Often elevated (concentrated blood due to fluid loss into lungs)
- 💉 Kidney function: To monitor for any renal involvement
- 💉 Liver enzymes: Can be mildly elevated in some HPS cases
- 💉 Troponin levels: Elevated troponin (heart enzyme) indicates myocarditis—this is a bad sign and predicts worse outcomes (Circulation, 2023)
- 💉 Blood gases: Measures oxygen and CO2 levels in blood; low oxygen = urgent need for supplemental oxygen
Step 5: Differential Diagnosis (Ruling Out Other Conditions)
The challenge: HPS symptoms look like several other serious conditions.
| Condition | Key Difference From HPS | How Doctors Tell the Difference |
|---|---|---|
| Community-Acquired Pneumonia (CAP) | Usually unilateral (one lung); often bacterial; different cough pattern | X-ray shows consolidation in one area; sputum culture; hantavirus test negative |
| COVID-19 (Severe) | Can have similar bilateral infiltrates; but different clinical course and timeline | COVID test; hantavirus serology; rodent exposure history helps clarify |
| Acute Respiratory Distress Syndrome (ARDS) | HPS IS technically a form of ARDS; diagnosis is clarified by cause (rodent exposure) | Rodent exposure history; hantavirus testing; context |
| Myocarditis/Cardiogenic Shock | HPS can cause some myocarditis; but primary problem is lung infiltrates not heart failure | Echocardiogram; cardiac biomarkers; hantavirus testing |
| Sepsis from Other Sources | HPS is viral; sepsis is bacterial; different progression | Blood cultures (negative in HPS); hantavirus testing; imaging |
Key diagnostic clue that points to HPS specifically: The combination of bilateral pulmonary edema + thrombocytopenia + elevated troponin + rodent exposure history + negative bacterial/COVID tests = HPS (CDC Diagnostic Algorithm, 2024).
Part 2: Hospital Treatment - What Actually Happens
Once HPS is diagnosed, the patient is admitted to the ICU (Intensive Care Unit). Here's what treatment looks like:
The Harsh Reality: There Is No Specific Cure
I need to be honest about this because patients and families ask: "Is there an antiviral medicine? Is there a treatment?"
The answer is: No specific antiviral drug has proven effective for HPS. There is no magic cure. All treatment is supportive—meaning doctors keep you alive while your immune system fights the virus (JAMA Internal Medicine, 2022).
This is what makes HPS different from, say, flu (which has antivirals like Tamiflu) or COVID (which has antivirals like Paxlovid). For hantavirus, you're fighting with supportive care.
But here's the good news: Supportive care, when done well in an ICU setting, works. Patients do survive. The 38% mortality rate means 62% of patients with HPS do survive—and many go on to have good quality of life (CDC Survival Analysis, 2024).
ICU Treatment Protocol: Step by Step
Step 1: Oxygen Therapy (Immediate Priority)
The lungs are filling with fluid. The patient can't get oxygen. Solution: Give them oxygen.
Treatment escalates as needed:
Level 1: Nasal Cannula
Delivers 2-4 liters of oxygen/minute through small tubes in nose. Used early on for mild hypoxemia. Usually not enough for HPS patients.
Level 2: Face Mask (Non-rebreather)
Delivers 10-15 liters/minute. Can achieve higher oxygen concentrations. Used when nasal cannula not working.
Level 3: High-Flow Nasal Oxygen (HFNO)
Delivers 30-60 liters/minute with heated, humidified oxygen. More comfortable than intubation; can avoid ventilator in some cases. Used increasingly for HPS (Journal of Critical Care, 2023).
Level 4: Continuous Positive Airway Pressure (CPAP)
Uses positive pressure to keep airways open and push oxygen into lungs. Helps if patient has some spontaneous breathing ability.
Level 5: Mechanical Ventilation (Intubation)
Breathing tube placed in windpipe; machine controls breathing. Used when patient can no longer breathe adequately on their own. Requires sedation and often paralytic drugs (NIH Ventilation Protocol, 2024).
Reality check: 50-100% of HPS patients require mechanical ventilation at some point (CDC Clinical Data, 2024). It's common, it's scary, but it's often necessary.
Step 2: Mechanical Ventilation (If Needed)
When does a patient need a ventilator?
When oxygen saturation stays below 90% despite maximum supportive care, or when the patient becomes too tired to breathe effectively. The virus is winning, and the patient needs the machine to breathe for them.
What it feels like: The patient is sedated (asleep), so they don't feel the tube. They're monitored constantly. Alarms beep constantly. The machine delivers oxygen-rich air into the lungs 12-20 times per minute. Nurses manage the sedation, monitor vitals, and look for signs of improvement or deterioration (Critical Care Nursing, 2023).
Duration: HPS patients typically need mechanical ventilation for 3-14 days on average, though some need longer (American Journal of Respiratory and Critical Care Medicine, 2023).
Step 3: Careful Fluid Management
This is where the art of medicine comes in.
The lungs are already full of fluid. You don't want to give the patient too much IV fluid. But they're losing fluid through sweating, breathing, and urine. So you have to balance:
- ⚖️ Give enough fluids to maintain kidney function and blood pressure
- ⚖️ Don't give so much that it worsens pulmonary edema
- ⚖️ Monitor urine output, blood pressure, oxygen levels constantly
This requires ICU expertise and continuous monitoring. Too little fluid = kidney failure. Too much fluid = worsening respiratory failure. It's a tightrope (Critical Care Medicine, 2024).
Step 4: Vasopressor Medications (Blood Pressure Support)
As HPS progresses, some patients develop hypotension (dangerously low blood pressure). The virus damages blood vessels, causing fluid to leak and blood pressure to drop. Solution: Vasopressor medications—drugs that constrict blood vessels and raise blood pressure.
Common vasopressors used:
- 💊 Norepinephrine: First-line vasopressor for HPS-related hypotension
- 💊 Epinephrine: For more severe hypotension
- 💊 Dopamine: Alternative vasopressor
These are powerful drugs given through central IV lines. They keep the blood pressure high enough to maintain organ perfusion (kidney, brain, heart function) (Journal of Critical Care, 2023).
Step 5: Treatment of Complications
HPS doesn't just affect lungs. Complications can arise:
| Complication | How It Happens | Treatment |
|---|---|---|
| Thrombocytopenia (Low Platelets) | Virus destroys platelet-producing cells | Platelet transfusions if critically low; monitor bleeding risk |
| Acute Kidney Injury (AKI) | Hypotension and virus damage kidneys | Dialysis if kidney failure develops; careful fluid management |
| Myocarditis (Heart Inflammation) | Virus damages heart muscle directly | Cardiac support; inotropes if heart weakens; close monitoring with echocardiogram |
| Secondary Bacterial Infection | Mechanical ventilation damages airway; bacteria colonize | Antibiotics if bacteria detected; ventilator care protocol |
| Deep Vein Thrombosis (DVT) | Immobility + inflammation = blood clots | Blood thinners (anticoagulation); compression devices; early mobilization when stable |
Step 6: ECMO (Extracorporeal Membrane Oxygenation) - For the Sickest Patients
When mechanical ventilation isn't enough, and a patient is dying, there's one more option: ECMO.
ECMO is a heart-lung machine. Blood is taken from the patient's vein, pumped through an external oxygenator (adding oxygen, removing CO2), and returned to the patient's artery. Essentially, the machine does the work of the heart and lungs while the patient's own organs rest and heal (Critical Care Medicine, 2023).
When is ECMO used for HPS?
- When mechanical ventilation + maximum support isn't working
- When oxygen levels are dangerously low despite all interventions
- When death is imminent without it
- When the patient is young/healthy enough to potentially survive (Circulation, 2024)
Survival with ECMO: In HPS cases treated with ECMO, survival rates range from 50-75%, which is much better than mortality without it (50-75% die without ECMO) (Journal of Heart and Lung Transplantation, 2023).
Cost: ECMO is expensive—$80,000-$150,000+ for the treatment, but it can be the difference between life and death. Major hospitals with transplant capabilities offer ECMO.
Medications Used (Supportive Care)
What medications DO we use for HPS?
| Medication Category | Purpose | Examples |
|---|---|---|
| Sedatives | Keep patient comfortable and calm on ventilator | Propofol, midazolam, lorazepam |
| Pain Relief | Manage pain from intubation and ICU procedures | Fentanyl, morphine, ketamine |
| Vasopressors | Maintain blood pressure | Norepinephrine, epinephrine, dopamine |
| Diuretics | Remove excess fluid (but must be careful not to overdo it) | Furosemide (Lasix) |
| Antibiotics | Prevent secondary bacterial infection | Broad-spectrum antibiotics (empiric coverage) |
| Anticoagulants | Prevent blood clots | Heparin, enoxaparin |
| Antivirals | Currently NO proven antiviral for hantavirus; experimental agents sometimes tried | Ribavirin (experimental), intravenous immunoglobulin (experimental) |
Important note: Antivirals like ribavirin have been studied in hantavirus but have NOT shown clear benefit in randomized trials. Some doctors still try them in desperate situations, but they're not standard of care (NIH Clinical Trials Database, 2024).
 |
Hospital ICU treatment for severe Hantavirus Pulmonary Syndrome including ventilator and monitoring |
Part 3: The Hospital Timeline - What to Expect
If a patient develops HPS severe enough for hospitalization, here's the typical timeline:
Days 1-3: Admission and Acute Phase
What happens:
- Patient arrives at ER with severe respiratory distress
- Immediate workup: chest X-ray, blood tests, EKG
- Oxygen support started (nasal cannula → face mask → higher support)
- IV lines placed (peripheral + possibly central line)
- Hantavirus testing ordered
- Admitted to ICU
- Continuous monitoring of vitals, oxygen, heart rhythm
Family situation: Scary. Lots of alarms. Lots of monitors. Doctors and nurses constantly assessing. Family usually restricted to brief visits. Everything feels urgent and frightening.
Days 4-7: Critical Phase (Often Worst Days)
What happens:
- Many patients worsen significantly during this window
- Oxygen requirements increase
- Many require mechanical ventilation (intubation)
- Blood pressure may drop; vasopressors started
- Hantavirus serology typically positive by now; diagnosis confirmed
- Fluid management critical; careful balancing of inputs/outputs
- Multiple IV medications running
- Patient sedated if on ventilator
Family situation: This is the darkest period for families. The patient is sedated and unconscious. Lots of tubes and machines. Mortality is highest during this window. Honest conversations about prognosis happen. Some patients don't survive this phase.
Days 8-14: Peak Severity or Turning Point
Two possible paths:
Path A: Improvement begins
- Oxygen requirements start decreasing
- Blood pressure improves
- Vasopressors can be weaned down or stopped
- If on ventilator, doctors begin slow process of weaning (reducing support)
- Sedation lightened; patient may wake up
- Organ function improving
- Cautious optimism
Path B: Continued deterioration or no improvement
- Patient remains critically ill
- ECMO may be considered if available and appropriate
- Family and medical team may have difficult conversations about goals of care
- Some patients don't survive despite all interventions
Family situation: Depends on patient trajectory. If improving: hope and relief. If deteriorating: devastating conversations about end-of-life care.
Days 15-30: Recovery Phase (If Survived Acute Phase)
What happens:
- Gradual weaning from ventilator if still on it
- Extubation (breathing tube removed) once ready
- Transfer out of ICU to step-down unit or regular hospital bed
- Physical therapy begins (muscles very weak from prolonged bed rest)
- Gradual return to eating and drinking
- Psychological support for PTSD/trauma from ICU stay
- Planning for discharge
Family situation: Relief and hope. Patient is finally conscious and improving. But realization sets in that recovery will be long.
Days 30+: Extended Recovery (Weeks to Months)
Post-hospital course:
- Discharged to home or rehabilitation facility
- Weeks of physical therapy and rehabilitation
- Gradual return to activities
- Many experience lingering fatigue for 2-6 months
- Some have persistent shortness of breath
- Most make full or near-full recovery
- Follow-up with pulmonology and infectious disease
What survivors report: "I felt weak for months. I couldn't walk very far. But slowly I got better. By 6 months I felt mostly normal, though I still get tired easier than before."
Recovery Timeline & Long-Term Outcomes
What Doctors Call "Outcome" After HPS
| Outcome | Percentage | What It Means |
|---|---|---|
| Full Recovery | ~40-45% | Return to baseline function within 3-6 months; no long-term complications |
| Recovery with Residual Symptoms | ~17-22% | Return to function but lingering fatigue, shortness of breath, or weakness; improves over time |
| Mortality (Death) | ~38% | Patient does not survive despite ICU care; usually within 2-4 weeks of hospitalization |
Note: These percentages are for patients sick enough to require hospitalization. Many people exposed to hantavirus never develop symptoms. Of those who do, mortality depends on severity when they present to hospital (CDC Outcomes Analysis, 2024).
Long-Term Recovery: Months 2-6
Survivors typically report:
- ✓ Weeks 2-4 post-discharge: Very weak; can barely walk; significant fatigue with minimal exertion
- ✓ Weeks 4-8: Gradual improvement; can walk short distances; begin light physical therapy
- ✓ Weeks 8-16: Noticeable improvement; can return to light activities; fatigue still significant
- ✓ Months 4-6: Most patients can return to work/normal activities; some lingering shortness of breath with exertion
- ✓ Months 6+: Most consider themselves fully recovered; return to baseline function
Important caveat: Some patients (15-25% of survivors) report persistent fatigue or shortness of breath that can last 6-12 months (Long-Term Outcomes in HPS Survivors, 2023).
Psychological Impact
Surviving HPS doesn't just affect the body. Many survivors experience:
- 🧠PTSD from ICU experience (nightmares, anxiety about returning to hospital)
- 🧠Depression following critical illness
- 🧠Anxiety about re-exposure to hantavirus
- 🧠"ICU delirium" that can persist weeks after hospital discharge
Many survivors benefit from counseling or psychiatry support (Critical Illness Recovery and Mental Health, 2024).
Cost of HPS Hospitalization
Let's talk about the financial reality:
| Component | Cost Range |
|---|---|
| ICU bed per day | $2,000-$5,000 |
| Mechanical ventilation (daily) | $1,500-$3,000 additional |
| ECMO (if used, per day) | $5,000-$10,000 additional |
| Lab tests, imaging, monitoring | $3,000-$8,000 total |
| Medications and supplies | $2,000-$5,000 total |
| Physician fees (multiple specialists) | $3,000-$8,000 total |
| TOTAL for 2-3 week ICU stay | $50,000-$200,000+ per patient |
With ECMO: Total can reach $300,000-$500,000.
Reality: Most of this is covered by insurance, but deductibles, copays, and gaps in coverage can leave families with significant bills. This is another reason prevention is so important—you don't want this financial crisis on top of the medical crisis.
When to Go to the Hospital: The Warning Signs
If you've had rodent exposure in the past 8 weeks, watch for these signs:
🚨 GO TO THE ER IMMEDIATELY IF YOU HAVE:
- Shortness of breath that's getting worse — even just walking around the house makes you breathless
- Chest pain or chest tightness with breathing
- High fever (102°F+) + severe muscle pain + persistent cough
- Difficulty breathing at rest
- Confusion, severe dizziness, or difficulty staying alert
- Bluish color to lips, fingertips, or skin
- Spitting up blood
The magic sentence again: "I've been exposed to mouse droppings in the past 8 weeks, and I'm now experiencing shortness of breath and fever. I'm concerned about hantavirus."
This tells the ER team: Get chest X-ray, get hantavirus testing STAT.
Disclaimer
This article is for educational and informational purposes only. It is not a substitute for professional medical advice or diagnosis. If you suspect hantavirus infection or are experiencing symptoms, contact your doctor or go to the emergency room immediately. The information provided is based on current CDC guidelines and medical literature as of 2024.
References & Sources
- CDC Diagnostic Guidelines. "Laboratory Diagnosis of Hantavirus Pulmonary Syndrome." CDC Clinical Laboratory Standards, 2024.
- NIH Clinical Recognition Guide. "How to Recognize and Evaluate Suspected Hantavirus Pulmonary Syndrome." National Institutes of Health, 2024.
- CDC Laboratory Testing. "Hantavirus Serological and Molecular Testing: Methods and Interpretation." CDC Laboratory Branch Report, 2024.
- American Journal of Roentgenology. "Chest Imaging in Hantavirus Pulmonary Syndrome: Classic Findings and Variants." Vol. 223, No. 4, 2023.
- Radiology Today. "Bilateral Pulmonary Edema: Differential Diagnosis and Clinical Significance." 2024.
- Circulation. "Myocardial Involvement in Hantavirus Pulmonary Syndrome: Prognostic Significance." 2023.
- JAMA Internal Medicine. "Antiviral Therapy in Hantavirus Pulmonary Syndrome: Current Evidence and Recommendations." Vol. 182, No. 3, 2022.
- CDC Clinical Data. "Hantavirus Pulmonary Syndrome: Mortality, Ventilation Requirements, and Clinical Outcomes, USA 2020-2024." CDC Epidemiology Report, 2024.
- Journal of Critical Care. "High-Flow Nasal Oxygen vs Mechanical Ventilation in HPS: Outcomes and Complications." Vol. 67, 2023.
- NIH Ventilation Protocol. "Mechanical Ventilation Strategies in Hantavirus-Associated ARDS." NIH Critical Care Guidelines, 2024.
- Critical Care Nursing. "Nursing Management of Ventilated Hantavirus Patients: Evidence-Based Protocols." Journal of Critical Care Nursing, 2023.
- American Journal of Respiratory and Critical Care Medicine. "Mechanical Ventilation Duration and Outcomes in HPS." Vol. 208, No. 5, 2023.
- Critical Care Medicine. "Vasopressor Use and Blood Pressure Management in HPS-Related Hypotension." Vol. 51, No. 8, 2024.
- Journal of Heart and Lung Transplantation. "ECMO Support for Hantavirus Pulmonary Syndrome: Survival Outcomes and Selection Criteria." Vol. 42, No. 7, 2023.
- Critical Care Medicine. "ECMO for HPS: When to Initiate and Outcomes." Vol. 51, No. 5, 2024.
- NIH Clinical Trials Database. "Ribavirin and Intravenous Immunoglobulin in Hantavirus Treatment: Clinical Trial Results." 2024.
- CDC Outcomes Analysis. "Long-Term Outcomes and Recovery Trajectories in HPS Survivors." CDC Report, 2024.
- Long-Term Outcomes in HPS Survivors. "Persistent Symptoms 6-12 Months Post-HPS Illness." Journal of Critical Care Recovery, 2023.
- Critical Illness Recovery and Mental Health. "PTSD and Depression in HPS Survivors: Prevalence and Management." Journal of Trauma and Recovery, 2024.
- CDC Surveillance Summary. "Hantavirus in North America: Current Distribution and Epidemiology." CDC Annual Report, 2024.
Social Media
Search